Verano Announces Upcoming Conference Participation

Rhea-AI Summary

Verano Holdings Corp. (OTCQX: VRNOF), a leading multi-state cannabis company, has announced its participation in upcoming conferences. Key events include:

1. ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference on September 18, 2024, in New York, NY. Aaron Miles, Chief Investment Officer, will join investor meetings and a panel on Florida and other cannabis catalysts.

2. Benzinga Cannabis Capital Conference in Chicago, IL, on October 8-9, 2024. Multiple Verano executives will participate:

• Darren Weiss, President, on a panel discussing life after 280E
• George Archos, Founder, Chairman and CEO, in the Day 1 Closing Keynote Discussion
• Julianna Paterra, VP of Investor Relations, on a panel about cannabis capital markets outlook for 2025

These events provide opportunities for Verano to share insights on industry trends and company strategies.

CHICAGO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the following conference participation:

ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference
Aaron Miles, Chief Investment Officer, will participate in 1x1 investor meetings and a panel titled Green Horizons: Florida and Other Upcoming Catalysts in Cannabis.
DATE: September 18, 2024
LOCATION: New York, NY
TIME: 12:00 p.m. ET

Benzinga Cannabis Capital Conference
Darren Weiss, President, will participate in a panel titled Life After 280E, Different Companies, Different Scenarios: More Money For All?
DATE: October 8, 2024
LOCATION: Chicago, IL
TIME: 9:40 a.m. CT

Benzinga Cannabis Capital Conference
George Archos, Founder, Chairman and Chief Executive Officer, will participate in the Day 1 Closing Keynote Discussion.
DATE: October 8, 2024
LOCATION: Chicago, IL
TIME: 4:50 p.m. CT

Benzinga Cannabis Capital Conference
Julianna Paterra, Vice President of Investor Relations, will participate in a panel titled Cannabis Capital Markets: What do the Industry’s Leading Operators Expect from 2025?
DATE: October 9, 2024
LOCATION: Chicago, IL
TIME: 10:00 a.m. CT

About Verano

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf^™ and MÜV^™ dispensary banners, including Cabbage Club^™, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano^™, (the) Essence^™, MÜV^™, Savvy^™, BITS^™, Encore^™, and Avexia^™. Verano’s active operations span 14 U.S. states, comprised of 15 production facilities with over 1,100,000 square feet of cultivation capacity. Learn more at Verano.com.
Contacts:

Media
Verano
Steve Mazeika
Vice President, Communications
Steve.Mazeika@verano.com
312-348-4430

Investors
Verano
Julianna Paterra, CFA
Vice President, Investor Relations
investors@verano.com

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q, in each case, filed with the U.S. Securities and Exchange Commission at www.sec.gov.The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.
##

FAQ

When is Verano (VRNOF) participating in the ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference?

Verano (VRNOF) is participating in the ATB Capital Markets 2024 Fall Life Sciences Institutional Investor Conference on September 18, 2024, in New York, NY.

Who from Verano (VRNOF) is speaking at the Benzinga Cannabis Capital Conference in October 2024?

Three Verano (VRNOF) executives are speaking at the Benzinga Cannabis Capital Conference: Darren Weiss (President), George Archos (Founder, Chairman and CEO), and Julianna Paterra (VP of Investor Relations).

What panel is Verano's (VRNOF) Chief Investment Officer participating in at the ATB Capital Markets conference?

Aaron Miles, Verano's (VRNOF) Chief Investment Officer, is participating in a panel titled 'Green Horizons: Florida and Other Upcoming Catalysts in Cannabis' at the ATB Capital Markets conference.

When and where is the Benzinga Cannabis Capital Conference that Verano (VRNOF) is attending in 2024?

The Benzinga Cannabis Capital Conference that Verano (VRNOF) is attending is on October 8-9, 2024, in Chicago, IL.

What topic will Verano's (VRNOF) President discuss at the Benzinga Cannabis Capital Conference?

Darren Weiss, Verano's (VRNOF) President, will participate in a panel titled 'Life After 280E, Different Companies, Different Scenarios: More Money For All?' at the Benzinga Cannabis Capital Conference.